SCHEMBL7657583

SCHEMBL7657583

N=C(N)c1ccc(NC(=O)c2ccccc2-c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 5/20 0.71
PLAT P00750 5/20 0.71
F10 P00742 8/20 0.63
F2 P00734 6/20 0.63
PLG P00747 3/20 0.63
CHRNB2 P17787 1/20 0.60
CHRNB4 P30926 1/20 0.60
CHRNA3 P32297 1/20 0.60
CHRNA4 P43681 1/20 0.60
PRSS1 P07477 3/20 0.59
PRSS2 P07478 3/20 0.59
PRSS3 P35030 3/20 0.59
KLK1 P06870 4/20 0.57
KLK5 Q9Y337 4/20 0.57
F7 P08709 2/20 0.57
F3 P13726 2/20 0.57
ALDH1A1 P00352 1/20 0.53
POLB P06746 1/20 0.53
GAA P10253 1/20 0.53
CYP3A4 P08684 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656744 0.94 PLAU (0.64) PLAUPLATF10F2PLG
SCHEMBL7661930 0.88 CYP3A4 (0.69) PLAUPLATF10F2PLG
SCHEMBL7659610 0.88 PLAU (0.69) PLAUPLATF10F2PLG
SCHEMBL2571393 0.87 CHRNB2 (0.78) PLAUPLATCHRNB2CHRNB4CHRNA3
Hydrochloric Acid SCHEMBL7655131 0.86 CYP3A4 (0.68) PLAUPLATF10F2PLG
SCHEMBL7657658 0.85 F2 (0.73) PLAUPLATF10F2PLG
SCHEMBL7372972 0.84 CHRNB2 (0.63) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL7660234 0.83 PLAU (0.66) PLAUPLATF10F2PLG
SCHEMBL7663326 0.83 F10 (0.67) PLAUPLATF10F2PLG
SCHEMBL7659008 0.83 PLAU (0.62) PLAUPLATF10F2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed